Morphine and its psychiatric implications.
Division of Psychiatry, Brigham and Women's Hospital, Boston, MA 02115.
G L
GL
Fricchione
A
A
Mendoza
G B
GB
Stefano
D000818:Animals; D001010:Anxiety, Separation / Q000378:metabolism; D002409:Cathexis; D004298:Dopamine / Q000502:physiology; D005786:Gene Expression Regulation; D016762:Genes, fos; D006801:Humans; D008032:Limbic System / Q000503:physiopathology; D008322:Mammals / Q000502:physiology; D001523:Mental Disorders / Q000378:metabolism; D008954:Models, Biological; D009020:Morphine / Q000009:adverse effects / Q000378:metabolism*; D018847:Opioid Peptides / Q000502:physiology; D010121:Oxytocin / Q000502:physiology; D051381:Rats; D017450:Receptors, Opioid, mu / Q000187:drug effects / Q000502:physiology; D013312:Stress, Physiological / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000378:metabolism*; D013681:Tegmentum Mesencephali / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D018847:Opioid Peptides; D017450:Receptors, Opioid, mu; D010121:Oxytocin; D005680:gamma-Aminobutyric Acid; D009020:Morphine; D004298:Dopamine